Publications by authors named "F Glass"

Multimachine empirical scaling predicts an extremely narrow heat exhaust layer in future high magnetic field tokamaks, producing high power densities that require mitigation. In the experiments presented, the width of this exhaust layer is nearly doubled using actuators to increase turbulent transport in the plasma edge. This is achieved in low collisionality, high confinement edge pedestals with their gradients limited by turbulent transport instead of large-scale, coherent instabilities.

View Article and Find Full Text PDF

Background: Peroxisome proliferator-activated receptor gamma (PPARG) is a member of the nuclear receptor family. It is involved in the regulation of adipogenesis, lipid metabolism, insulin sensitivity, vascular homeostasis and inflammation. In addition, PPARG agonists, known as thiazolidinediones, are well established in the treatment of type 2 diabetes mellitus.

View Article and Find Full Text PDF

Recent upgrades providing two-dimensional divertor Thomson scattering (DTS-2D) measurements of Te and ne during a DIII-D plasma shot and a thorough description of system components and their functionality are presented. This system expands the capabilities of the existing single divertor Floor measurement location by introducing seven additional laser beam path options in the poloidal plane, spanning major radii from 1.062 to 1.

View Article and Find Full Text PDF

Mycosis fungoides (MF) is a slowly progressive form of cutaneous T-cell lymphomas (CTCL). MF is classified into 4 subtypes including folliculotropic MF (FMF). Infiltration of both hair follicles and eccrine glands is included in the FMF classification and designated as syringotropic MF (STMF), an exceedingly rare form of CTCL.

View Article and Find Full Text PDF
Article Synopsis
  • TNF antagonists are game-changers for treating autoimmune diseases like rheumatoid arthritis and inflammatory bowel diseases, but they can have side effects that require switching medications.!
  • This text discusses a specific issue where a patient developed TNF-α antagonist-induced lupus syndrome (TAILS), which was shown through a condition called interstitial granulomatous dermatitis (IGD).!
  • The case presented is unique because it occurred in a patient with Crohn's disease, highlighting the complexities and potential complications of TNF antagonist treatments.!
View Article and Find Full Text PDF